Amgen Inc. (AMGN) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	38.1B	36.7B	33.4B	28.2B	26.3B
Cost of Revenue	10.4B	10.7B	12.9B	8.4B	6.4B
Gross Profit	27.7B	26.0B	20.6B	19.8B	19.9B
Operating Expenses
R&D Expense	7.6B	7.0B	6.0B	4.8B	4.4B
SG&A Expense	7.0B	7.0B	7.1B	6.2B	5.4B
General & Admin Expense	—	—	6.1B	—	4.6B
Selling & Marketing Expense	—	—	987.0M	—	841.0M
Other Expenses	408.0M	1.3B	248.0M	879.0M	503.0M
Total Operating Expenses	15.1B	15.3B	13.3B	11.8B	10.4B
Cost and Expenses	25.5B	26.1B	26.2B	20.3B	16.8B
Operating Income (EBIT)	12.6B	10.7B	7.3B	7.9B	9.6B
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	2.7B	2.8B	3.2B	2.9B	1.4B
Net Interest Income	(2.7B)	(2.8B)	(3.2B)	(2.9B)	(1.4B)
Other Non-Op Income/Expense	(2.4B)	(1.7B)	(2.6B)	(42.0M)	(2.2B)
Non-Operating Income (excl Interest)	(307.0M)	(1.1B)	(506.0M)	(2.8B)	814.0M
EBT (Pre-Tax Income)	10.3B	9.0B	4.6B	7.9B	7.3B
Income Tax Expense	1.5B	1.3B	519.0M	1.1B	794.0M
Bottom Line
Net Income	8.7B	7.7B	4.1B	6.7B	6.6B
Earnings from Cont. Ops	8.7B	7.7B	4.1B	6.7B	6.6B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	8.7B	7.7B	4.1B	6.7B	6.6B
Per Share
Basic EPS	$16.22	$14.33	$7.62	$12.56	$12.18
Diluted EPS	$16.09	$14.23	$7.56	$12.49	$12.11
Revenue Per Share	$70.60	$68.29	$61.78	$52.69	$48.93
Shares
Basic Shares Outstanding	540.0M	538.0M	541.0M	535.0M	538.0M
Diluted Shares Outstanding	544.0M	542.0M	541.0M	538.0M	541.0M
Profitability Metrics
EBITDA	16.5B	16.9B	13.4B	14.8B	12.2B
D&A	3.6B	5.2B	5.6B	4.1B	3.4B
EBIT	13.0B	11.7B	7.8B	10.7B	8.8B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026